Point of Care Testing Market Share Forecasts 2023-2032 

Point of Care Testing Market Size - By Product, By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application, By End-use – Global Forecast 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global point of care testing market 360&deg; synopsis, 2018 &ndash; 2032 (Revenue)

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Product trends

2.5&nbsp;&nbsp;&nbsp; Technology trends

2.6&nbsp;&nbsp;&nbsp; Prescription trends

2.7&nbsp;&nbsp;&nbsp; Application trends

2.8&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Point of Care Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Pricing analysis, by cardiac markers, 2022

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Industry impact forces

3.6.1&nbsp;&nbsp;&nbsp; Growth drivers

3.6.1.1&nbsp;&nbsp;&nbsp;Upward trend in disease prevalence among developing countries

3.6.1.2&nbsp;&nbsp;&nbsp;Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America

3.6.1.3&nbsp;&nbsp;&nbsp;Technological advancements

3.6.1.4&nbsp;&nbsp;&nbsp;Increasing R&amp;D investment

3.6.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.6.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory framework

3.6.2.2&nbsp;&nbsp;&nbsp;High cost of product development

3.7&nbsp;&nbsp;&nbsp; Growth potential analysis

3.7.1&nbsp;&nbsp;&nbsp; By product

3.7.2&nbsp;&nbsp;&nbsp; By technology

3.7.3&nbsp;&nbsp;&nbsp; By prescription

3.7.4&nbsp;&nbsp;&nbsp; By application

3.7.5&nbsp;&nbsp;&nbsp; By end-use

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis, 2022 (by region)

4.2.1&nbsp;&nbsp;&nbsp; Global market share analysis, 2022

4.2.2&nbsp;&nbsp;&nbsp; North America

4.2.3&nbsp;&nbsp;&nbsp; Europe

4.2.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.2.5&nbsp;&nbsp;&nbsp; Latin America

4.2.6&nbsp;&nbsp;&nbsp; MEA

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Company positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategy outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By Product (Revenue)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Glucose monitoring

5.2.1&nbsp;&nbsp;&nbsp; Strips

5.2.2&nbsp;&nbsp;&nbsp; Meters

5.2.3&nbsp;&nbsp;&nbsp; Lancets

5.3&nbsp;&nbsp;&nbsp; Cardiometabolic testing products

5.3.1&nbsp;&nbsp;&nbsp; Cardiac marker testing products

5.3.1.1&nbsp;&nbsp;&nbsp;hsTnl

5.3.1.2&nbsp;&nbsp;&nbsp;BNP

5.3.1.3&nbsp;&nbsp;&nbsp;D-dimer

5.3.1.4&nbsp;&nbsp;&nbsp;CK-MB

5.3.1.5&nbsp;&nbsp;&nbsp;Myoglobin

5.3.1.6&nbsp;&nbsp;&nbsp;Others

5.3.2&nbsp;&nbsp;&nbsp; Blood gas/electrolytes testing products

5.3.3&nbsp;&nbsp;&nbsp; HBA1C testing products

5.4&nbsp;&nbsp;&nbsp; Infectious disease testing products

5.4.1&nbsp;&nbsp;&nbsp; Influenza testing products

5.4.2&nbsp;&nbsp;&nbsp; HIV testing products

5.4.3&nbsp;&nbsp;&nbsp; Hepatitis C testing products

5.4.4&nbsp;&nbsp;&nbsp; Sexually transmitted disease (STD) testing products

5.4.5&nbsp;&nbsp;&nbsp; Healthcare-associated infection (HAI) testing products

5.4.6&nbsp;&nbsp;&nbsp; Respiratory infection testing products

5.4.7&nbsp;&nbsp;&nbsp; Tropical disease testing products

5.4.8&nbsp;&nbsp;&nbsp; Others

5.5&nbsp;&nbsp;&nbsp; Coagulation testing products

5.5.1&nbsp;&nbsp;&nbsp; PT/INR testing products

5.5.2&nbsp;&nbsp;&nbsp; Activated clotting time (ACT/APTT) testing products

5.6&nbsp;&nbsp;&nbsp; Pregnancy and fertility testing products

5.6.1&nbsp;&nbsp;&nbsp; Pregnancy testing products

5.6.2&nbsp;&nbsp;&nbsp; Fertility testing products

5.7&nbsp;&nbsp;&nbsp; Tumor/cancer marker testing products

5.8&nbsp;&nbsp;&nbsp; Cholesterol testing products

5.9&nbsp;&nbsp;&nbsp; Hematology testing products

5.10&nbsp;&nbsp;&nbsp; Drug-of-abuse (DoA) testing products

5.11&nbsp;&nbsp;&nbsp; Fecal occult testing products

5.12&nbsp;&nbsp;&nbsp; Urinalysis testing products

5.13&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By Technology (Revenue)

6.1&nbsp;&nbsp;&nbsp; Key trends, by technology

6.2&nbsp;&nbsp;&nbsp; Lateral flow assays

6.3&nbsp;&nbsp;&nbsp; Dipsticks

6.4&nbsp;&nbsp;&nbsp; Microfluidics

6.5&nbsp;&nbsp;&nbsp; Molecular diagnostics

6.6&nbsp;&nbsp;&nbsp; Immunoassays

6.7&nbsp;&nbsp;&nbsp; Agglutination assays

6.8&nbsp;&nbsp;&nbsp; Flow-through

6.9&nbsp;&nbsp;&nbsp; Solid phase

6.10&nbsp;&nbsp;&nbsp; Biosensors

Chapter 7&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By Prescription (Revenue)

7.1&nbsp;&nbsp;&nbsp; Key trends, by prescription

7.2&nbsp;&nbsp;&nbsp; OTC testing

7.3&nbsp;&nbsp;&nbsp; Prescription-based testing

Chapter 8&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By Application (Revenue)

8.1&nbsp;&nbsp;&nbsp; Key trends, by application

8.2&nbsp;&nbsp;&nbsp; Cardio metabolic testing

8.3&nbsp;&nbsp;&nbsp; Infectious disease testing

8.4&nbsp;&nbsp;&nbsp; Nephrology testing

8.5&nbsp;&nbsp;&nbsp; Drug-of-abuse (DoA) testing

8.6&nbsp;&nbsp;&nbsp; Blood glucose testing

8.7&nbsp;&nbsp;&nbsp; Pregnancy testing

8.8&nbsp;&nbsp;&nbsp; Cancer biomarker testing

8.9&nbsp;&nbsp;&nbsp; Others

Chapter 9&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By End-use (Revenue)

9.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

9.2&nbsp;&nbsp;&nbsp; Hospitals

9.3&nbsp;&nbsp;&nbsp; Diagnostic centers

9.4&nbsp;&nbsp;&nbsp; Research laboratories

9.5&nbsp;&nbsp;&nbsp; Home-care settings

9.6&nbsp;&nbsp;&nbsp; Others

Chapter 10&nbsp;&nbsp;&nbsp;Point of Care Testing Market Estimates and Forecast, By Region (Revenue)

10.1&nbsp;&nbsp;&nbsp; Key trends, by region

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Italy

10.3.5&nbsp;&nbsp;&nbsp; Spain

10.3.6&nbsp;&nbsp;&nbsp; Switzerland

10.3.7&nbsp;&nbsp;&nbsp; The Netherlands

10.3.8&nbsp;&nbsp;&nbsp; Denmark

10.3.9&nbsp;&nbsp;&nbsp; Poland

10.3.10&nbsp;&nbsp;&nbsp; Sweden

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; China

10.4.2&nbsp;&nbsp;&nbsp; Japan

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; South Korea

10.4.6&nbsp;&nbsp;&nbsp; New Zealand

10.4.7&nbsp;&nbsp;&nbsp; Thailand

10.4.8&nbsp;&nbsp;&nbsp; Vietnam

10.4.9&nbsp;&nbsp;&nbsp; Indonesia

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Colombia

10.5.5&nbsp;&nbsp;&nbsp; Chile

10.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

10.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.2&nbsp;&nbsp;&nbsp; South Africa

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Turkey

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abaxis

11.2&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.3&nbsp;&nbsp;&nbsp; ACON Laboratories, Inc

11.4&nbsp;&nbsp;&nbsp; Accubiotech Co, Ltd.

11.5&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

11.6&nbsp;&nbsp;&nbsp; bioLytical Laboratories Inc

11.7&nbsp;&nbsp;&nbsp; BioMerieux SA

11.8&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc

11.9&nbsp;&nbsp;&nbsp; HemoCue AB (Danaher Corporation)

11.10&nbsp;&nbsp;&nbsp; Dexcom, Inc

11.11&nbsp;&nbsp;&nbsp; Dragerwerk Ag &amp; Co

11.12&nbsp;&nbsp;&nbsp; LifeScan IP Holdings, LLC

11.13&nbsp;&nbsp;&nbsp; Medtronic Plc

11.14&nbsp;&nbsp;&nbsp; Meridian Bioscience

11.15&nbsp;&nbsp;&nbsp; Nova Biomedical

11.16&nbsp;&nbsp;&nbsp; OraSure Technologies

11.17&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

11.18&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

11.19&nbsp;&nbsp;&nbsp; Sysmex Corporation

11.20&nbsp;&nbsp;&nbsp; Trinity Biotech 
&nbsp;

Point of Care Testing Market

Request Discount

Industries

Information

Link

Global Headquarters